Dead or Alive? Is Viability Alone Enough?

Cell Count and Viability in Cell Therapy

Presenter: Greg Fendley, PhD / Senior Field Application Scientist

A reliable cell count and viability is critical to the development and release of cell therapy products.

In this webinar, we look at:

  • The history of cell therapy, how it has emerged as a driver in the biopharma industry
  • Factors to consider when assessing the overall health and viability of a cell therapy product
  • Different modes of cell death, describe the pathways involved and identify the systematic events that lead a cell to the point of no return
  • Automated methods and cell-based assays to measure cell death
  • How dying cells may initially register as viable, yet become functionally dead in downstream processes

Watch our webinar “Dead or alive? Is viability alone enough?” below